Skip to main content
. Author manuscript; available in PMC: 2017 Aug 23.
Published in final edited form as: Nat Rev Cancer. 2016 Aug 23;16(9):566–581. doi: 10.1038/nrc.2016.97

Table 3.

Commercial Developers of Engineered T cells

Company Engineered T Cell Technology in Development
Adaptimmune TCRs
Autolus CARs
Beijing Doing Biomedical CARs
Bellicum CARs, “suicide” switch
bluebird bio CARs
CARsgen CARs
CBMG CARs
Celgene CARs
Cellectis Allogeneic CARs
Celyad CARs
Formula Pharmaceuticals CARs (in cytokine induced killer cells)
Juno Therapeutics CARs, TCRs
Kite Pharma CARs, TCRs
Medigene TCRs
NantKwest CARs (in NK cells)
Novartis CARs
Opus Bio CARs
PersonGen Biomedicine CARs
Poseida Therapeutics CARs
Takara Bio CARs, TCR’s
Theravectys CARS, regulated expression
Unum CARs
Ziopharm/Intrexon CARs, regulatable expression